A detailed history of Nemes Rush Group LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Nemes Rush Group LLC holds 250 shares of BDX stock, worth $58,582. This represents 0.01% of its overall portfolio holdings.

Number of Shares
250
Previous 335 25.37%
Holding current value
$58,582
Previous $82.9 Million 29.52%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$225.07 - $246.17 $19,130 - $20,924
-85 Reduced 25.37%
250 $58.4 Million
Q1 2024

May 15, 2024

SELL
$233.45 - $247.73 $14,707 - $15,606
-63 Reduced 15.83%
335 $82.9 Million
Q4 2023

Feb 09, 2024

BUY
$232.24 - $267.23 $696 - $801
3 Added 0.76%
398 $97 Million
Q3 2023

Nov 09, 2023

SELL
$254.9 - $283.59 $9,941 - $11,060
-39 Reduced 8.99%
395 $102 Million
Q2 2023

Aug 02, 2023

BUY
$238.39 - $265.32 $103,461 - $115,148
434 New
434 $115 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $66.8B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Nemes Rush Group LLC Portfolio

Follow Nemes Rush Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nemes Rush Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nemes Rush Group LLC with notifications on news.